Fulgent Genetics

From Verify.Wiki
Jump to: navigation, search
Fulgent.jpg
www.fulgentgenetics.com
Fulgent Genetics
Type Public
Industry Biotechnology
Founded 2011
Headquarters Temple City, California 91780 United States
Key people Ming Hsieh (CEO), Han Lin Gao ( Chief Scientific Officer), Paul Kim (CFO) Cite error: Closing </ref> missing for <ref> tag

Fulgent Therapeutics, LLC is a pharmaceutical company focusing on developing and commercializing innovative cancer therapeutics. It focuses on providing genetic testing services to physicians with clinically actionable diagnostic information. It intends to provide tests to hospitals and medical institutions. The company was formerly known as Fulgent Diagnostics, Inc. and changed its name to Fulgent Genetics, Inc. in August 2016.
They have Accreditations from the following:

  • Clinical Laboratory Improvement Amendments (CLIA) License 2015-2017
  • College of American Pathologists (CAP) Accreditation 2017
  • California Clinical Laboratory License 2016
  • Florida Clinical Laboratory License 2016 - 2018
  • Pennsylvania Clinical Laboratory Permit 2016-2017
  • Maryland Medical Laboratory License 2015-2016

History

Controversies

Top 5 Recent Tweets

DateAuthorComment
October 21, 2020dakotafinancialZacks Investment Research Downgrades Fulgent Genetics $FLGT to Hold https://t.co/iWYNsnvmhr
October 21, 2020ZolmaxNewsShort Interest in Fulgent Genetics, Inc. $FLGT Expands By 23.9% https://t.co/Wpq32doUXJ
October 21, 2020ZolmaxNewsFulgent Genetics $FLGT Stock Rating Lowered by BidaskClub https://t.co/EGV7Wv3OOo
October 20, 2020WeekHeraldFulgent Genetics, Inc. $FLGT Sees Large Increase in Short Interest https://t.co/P4UTKfOsNM


Top 5 Recent News Headlines

Top 5 Lifetime Tweets

Top 5 Lifetime News Headlines

Verification history